Human prostate carcinoma cells as targets for herpes simplex virus thymidine kinase-mediated suicide gene therapy

Cancer Gene Therapy

Volumn 8, Issue 2, 2001, Pages 137-144

  Loimas, Sami ^a,b   Toppinen, Marjo Riitta ^a   Visakorpi, Tapio ^c   Jänne, Juhani ^a   Wahlfors, Jarmo ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF TAMPERE   (Finland)

Author keywords

Fusion gene; Gene therapy; Green fluorescent protein; Herpes simplex virus thymidine kinase; Prostate cancer; Viral vectors

Indexed keywords

GANCICLOVIR; GREEN FLUORESCENT PROTEIN; THYMIDINE KINASE; VIRUS VECTOR;

ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; FUSION GENE; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; LENTIVIRINAE; PRIORITY JOURNAL; PROSTATE CARCINOMA; SUICIDE GENE; TREATMENT OUTCOME;

ADENOVIRIDAE; HERPES; LENTIVIRUS; SEMLIKI FOREST VIRUS; SIMPLEXVIRUS; SINDBIS VIRUS;

EID: 0035100085     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700286     Document Type: Article

References (31)

1. Carcinoma of the prostate
2. Gene therapy for prostate cancer
3. Prospects for gene therapy in human prostate cancer
4. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy
5. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors
6. Herpes simplex virus thymidine kinase green fluorescent protein fusion gene: New tool for gene transfer studies and gene therapy
7. Evaluation of recombinant alphaviruses as vectors in gene therapy
8. Prostate cancer gene therapy - Herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models
9. Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer
10. In vivo gene therapy for prostate cancer: Preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectors
11. Local inflammatory response and vector spread after direct intraprostatic injection of a recombinant adenovirus containing the herpes simplex virus thymidine kinase gene and ganciclovir therapy in mice
12. Adenovirus-mediated suicide gene therapy using the herpes simplex virus thymidine kinase gene in cell and animal models of human prostate cancer: Changes in tumor cell proliferative activity
13. Evaluation of the biodistribution, persistence, toxicity, and potential of germ-line transmission of a replication-competent human adenovirus following intraprostatic administration in the mouse
14. In situ gene therapy for adenocarcinoma of the prostate: A phase I clinical trial
15. Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer
16. Prospects for herpes simplex virus thymidine kinase and cytokine gene transduction as immunomodulatory gene therapy for prostate cancer
17. "Bystander killing" induces apoptosis and is inhibited by forskolin
18. Establishment and characterization of a human prostatic carcinoma cell line (PC-3)
19. LNCaP model of human prostatic carcinoma
20. Isolation of a human prostate carcinoma cell line (DU 145)
21. Recombinant Semliki Forest virus infects and kills human prostate cancer cell lines and prostatic duct epithelial cells ex vivo
22. Chromosome identity of human prostate cancer cell lines, PC-3 and PPC-1
23. Relative efficiency of tumor-cell killing in vitro by 2 enzyme-prodrug systems delivered by identical adenovirus vectors
24. A novel gene therapy strategy for elimination of prostate carcinoma cells from human bone marrow
25. Lentiviral vectors: Turning a deadly foe into a therapeutic agent
26. DNA replication of first-generation adenovirus vectors in tumor cells
27. Reduced connexin 43 expression in high-grade, human prostatic adenocarcinoma cells
28. Gap-junctional communication in normal and neoplastic prostate epithelial cells and its regulation by cAMP
29. Impaired expression and post-translational processing of connexin 43 and down-regulation of gap junctional communication in neoplastic human prostate cells
30. Suppression of human prostate cancer cell growth by forced expression of connexin genes